Skip to main content
. Author manuscript; available in PMC: 2021 Mar 5.
Published in final edited form as: Lancet Neurol. 2020 May;19(5):391–401. doi: 10.1016/S1474-4422(20)30070-3

Figure 3: Kaplan-Meier plots of time to first relapse by concomitant autoimmune disease status in the full analysis set.

Figure 3:

(A) Patients with NMOSD without concomitant autoimmune diseases. (B) Patients with NMOSD with concomitant autoimmune diseases. Data shown includes censored patients. Short red and blue vertical lines show censored data. NMOSD=neuromyelitis optica spectrum disorder.